Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2026-01-05 @ 5:33 PM
Study NCT ID:
NCT05537766
Status:
TERMINATED
Last Update Posted:
2025-03-03
First Post:
2022-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
Sponsor:
Kite, A Gilead Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-27
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-08
First Submit QC Date:
None
Study First Post Date:
2022-09-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-27
Last Update Post Date:
2025-03-03
Last Update Post Date Type:
ACTUAL